Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiac markers: present and future.

M Plebani1, M Zaninotto

  • 1Department of Laboratory Medicine, University Hospital of Padua, Via Giustiniani, 2, I-35128 Padua, Italy.

International Journal of Clinical & Laboratory Research
|August 7, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neurofilament light chain and profilin-1 dynamics in 30 spinal muscular atrophy type 3 patients treated with nusinersen.

European journal of neurology·2024
Same author

Hook-effect in MAGLUMI immunoassay for serum anti-GAD antibodies in neurological disorders: When "wrong" matrix is the right choice.

Clinica chimica acta; international journal of clinical chemistry·2024
Same author

Vitamin K in CKD Bone Disorders.

Calcified tissue international·2021
Same author

SARS-CoV-2 containment in complex surgical units during the COVID-19 pandemic.

The British journal of surgery·2020
Same author

Dexamethasone measurement during low-dose suppression test for suspected hypercortisolism: threshold development with and validation.

Journal of endocrinological investigation·2020
Same author

Bone turnover markers, BMD and TBS after short-term, high-dose glucocorticoid therapy in patients with Graves' orbitopathy: a small prospective pilot study.

Journal of endocrinological investigation·2018
Same journal

Lack of association of fibrinogen, lipoprotein(a), and albumin excretion rate with low birthweight.

International journal of clinical & laboratory research·2001
Same journal

Assay of erythrocyte membrane fatty acids. Effects of storage time at low temperature.

International journal of clinical & laboratory research·2001
Same journal

Bovine seminal RNase induces apoptosis in normal proliferating lymphocytes.

International journal of clinical & laboratory research·2001
Same journal

Cigarette smoking as an aggravating factor in inflammatory tissue-destructive diseases. Increase in tumor necrosis Factor-alpha priming of peripheral neutrophils measured as generation of oxygen radicals.

International journal of clinical & laboratory research·2001
Same journal

Angiotensin converting enzyme DD genotype affects the changes of plasma plasminogen activator inhibitor-1 activity after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction patients.

International journal of clinical & laboratory research·2001
Same journal

Antigastric autoantibodies in Helicobacter pylori infection: role in gastric mucosal inflammation.

International journal of clinical & laboratory research·2001
See all related articles

Acute myocardial infarction is now common, but cardiac troponins significantly improve diagnosis and risk stratification for acute coronary syndromes. Myoglobin and troponin are key early and definitive cardiac markers.

Area of Science:

  • Cardiology
  • Laboratory Medicine
  • Biochemistry

Background:

  • Acute myocardial infarction (AMI) has shifted from rare to common in industrialized nations.
  • Laboratory medicine is vital for understanding coronary ischemic disease, plaque rupture, and risk factors.
  • Advances in biochemical markers have revolutionized AMI diagnosis and management.

Purpose of the Study:

  • To highlight the impact of new biochemical markers, especially cardiac troponins, on diagnosing and managing acute coronary syndromes (ACS).
  • To emphasize the role of myoglobin as an early marker and cardiac troponin (I or T) as a definitive marker for myocardial damage.
  • To discuss future research directions in cardiac marker standardization, bedside testing, and thrombogenesis markers.

Main Methods:

Related Experiment Videos

  • Review of advancements in laboratory medicine for coronary ischemic disease.
  • Focus on the discovery and application of cardiac troponins as diagnostic and prognostic tools.
  • Discussion of emerging markers for thrombogenesis and their role in atherosclerosis.

    • Main Results:

    • Cardiac troponins offer high specificity for diagnosing myocardial damage, improving risk stratification and outcome prediction in ACS.
    • A combination of an early marker (myoglobin) and a definitive marker (cardiac troponin) is recommended.
    • New markers of thrombogenesis and insights from vascular biology are crucial for understanding atherosclerosis and plaque stability.

    Conclusions:

    • Cardiac troponins represent a significant advancement in diagnosing and managing acute coronary syndromes.
    • Future research should focus on standardizing troponin assays, developing rapid tests, and integrating thrombogenesis markers.
    • Laboratory tests, including biochemical, immunological, and coagulative markers, will enhance the diagnosis and therapy of ischemic coronary diseases.